Simplex Trading’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,200
Closed -$21K 8937
2023
Q4
$21K Buy
1,200
+140
+13% +$2K ﹤0.01% 6875
2023
Q3
$13K Buy
1,060
+40
+4% +$606 ﹤0.01% 6969
2023
Q2
$17K Buy
1,020
+33
+3% +$568 ﹤0.01% 6920
2023
Q1
$15K Buy
987
+387
+65% +$7.51K ﹤0.01% 7174
2022
Q4
$10K Sell
600
-1,267
-68% -$22.8K ﹤0.01% 7519
2022
Q3
$31K Sell
1,867
-653
-26% -$14.3K ﹤0.01% 7015
2022
Q2
$55K Sell
2,520
-640
-20% -$15.5K ﹤0.01% 6360
2022
Q1
$108K Buy
3,160
+1,713
+118% +$51.3K ﹤0.01% 6022
2021
Q4
$59K Sell
1,447
-120
-8% -$7.77K ﹤0.01% 7031
2021
Q3
$113K Hold
1,567
﹤0.01% 6446
2021
Q2
$114K Buy
1,567
+1,566
+156,600% +$72.8K ﹤0.01% 6531
2021
Q1
$2K Buy
+1
New +$50 ﹤0.01% 8430
2020
Q1
Sell
-22
Closed -$97K 7657
2019
Q4
$97K Buy
+22
New +$462 ﹤0.01% 4545
2019
Q1
Sell
-2
Closed -$3K 7190
2018
Q4
$3K Sell
2
-2
-50% -$94 ﹤0.01% 6404
2018
Q3
$37K Sell
4
-21
-84% -$2.5K ﹤0.01% 5446
2018
Q2
$404K Buy
25
+23
+1,150% +$3.88K ﹤0.01% 2676
2018
Q1
$4K Buy
+2
New +$244 ﹤0.01% 4759

Other funds holding CLSD

Simplex Trading's CLSD Position: Q3 2025 in Review

Simplex Trading sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 8 shares.

Simplex Trading first reported a position in CLSD in Q2 2018 and held it in 20 quarters. The position peaked at $308K in Q2 2018. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Simplex Trading reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 8 Clearside Biomedical shares in Q3 2025.
  • Simplex Trading first reported a position in Clearside Biomedical in Q2 2018 and held it in 20 quarters.
  • Simplex Trading's Clearside Biomedical position peaked at $308K in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.